- 1782918
- (Reference :Chercheur Scientifique Sénior)
-
Senior Research Scientist
DESCRIPTION
- 2012-08-31
- To be discussed
Project leader for the development of formulations. The candidate is in charge of completing typical drug development with the support of research chemists. Tasks will include literature review, active pharmaceutical ingredient development and scale-up, parenteral formulation development, lyophilization cycle development, process development and validation, analytical methods development and validation, timeline establishment, project status review, risk assessment, patent filing, regulatory support for US, European and Canadian agencies filings, QC and manufacturing operations troubleshooting.
Qualifications/skills required
•PHD in Chemistry: synthetic with analytical background, process development, radiopharmaceutical development.
•Minimum 2 years of experience in pharmaceutical industry (R&D)
•Team leader, fast thinking and troubleshooting oriented
•Capable of multi-tasking
•Objective and timeline driven
•Proactive with versatile skills along with broad and acute chemistry knowledge
•Knowledgeable on up and coming technologies
•Concise and precise in information sharing
•Organized, autonomous, in a research lab and able to instruct personnel
•Can operate commonly used laboratory instruments (HPLC, GC, UV, FTIR, NMR, Biotage purification system…)
•Should also be comfortable with organic chemistry / organometallic chemistry/ synthetical technics including distillation, recrystallization, liquid chromatography and precipitation.
•Experience in radiopharmaceutical development (Tc-99m, I-125, I-131) would be an asset.
•Fluent in English and French (work environment), with documentation reported in English.
Requirements
- Essential - PHD in Chemistry: synthetic with analytical backgr
- Essential - Minimum 2 years of experience in pharmaceutical in
- Important - Can operate commonly used laboratory instruments (
- Important - Should also be comfortable with organic chemistry
- Asset - Experience in radiopharmaceutical development (Tc-
